Clinical trial
NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing…
NCT00279084 · Hospices Civils de Lyon, Other · Unknown status
Key facts
| NCT number | NCT00279084 |
|---|---|
| Title | NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels |
| Official title | Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels (110- 129 g/L and 130 - 149 g/L) on Progression of Chronic Kidney Disease in Patients With Type 2 Diabetes and With Chronic Kidney Disease |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | GROUP A: if necessary, martial treatment and / or erythropoietin treatment to achieve the goal of haemoglobin level from 110 to 129 g/L., GROUP B: martial treatment and / or erythropoietin treatment to achieve the goal of haemoglobin level from 130 to 149 g/L |
| Enrollment | 204 |
| Start date | Jan 1, 2004 |
| First posted | Jan 19, 2006 |
| Last update posted | Oct 4, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: